Viewing Study NCT00868634


Ignite Creation Date: 2025-12-25 @ 2:18 AM
Ignite Modification Date: 2026-02-06 @ 4:54 PM
Study NCT ID: NCT00868634
Status: COMPLETED
Last Update Posted: 2016-08-31
First Post: 2009-03-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Capecitabine and Bevacizumab ± Vinorelbine in Metastatic Breast Cancer
Sponsor: iOMEDICO AG
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module